Announcements Trials
Browse Landscape

Phase

Phase NA 33Phase 4 3Phase 2 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 117Neoplasms 101Prostatic Neoplasms 76Carcinoma, Non-Small-Cell Lung 75Colorectal Neoplasms 73Carcinoma, Hepatocellular 67Leukemia, Myeloid, Acute 58Stomach Neoplasms 52Neoplasm Metastasis 50Lung Neoplasms 48Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Pancreatic Neoplasms 40Recurrence 36Head and Neck Neoplasms 32Rectal Neoplasms 30Colonic Neoplasms 30Leukemia 29Multiple Myeloma 28Ovarian Neoplasms 26Lymphoma 25Squamous Cell Carcinoma of Head and Neck 24Hematologic Neoplasms 23Melanoma 22Urinary Bladder Neoplasms 20Liver Neoplasms 20Polycystic Ovary Syndrome 19Myelodysplastic Syndromes 19Lymphoma, Large B-Cell, Diffuse 19Esophageal Neoplasms 19Uterine Cervical Neoplasms 16

Interventions

Testosterone 1Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Interventional × Metabolic Syndrome × Clear all
NCT02991209 2020-03-06

Einstein

Rigshospitalet, Denmark

Phase 2/3 Completed
69 enrolled
Genitourinary

Testicular Neoplasms, Metabolic Syndrome

NCT00111956 2017-10-06

Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 2/3 Completed
56 enrolled

Inflammation, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡